UK Markets closed
  • NIKKEI 225

    -111.97 (-0.40%)

    +635.41 (+3.38%)

    -0.38 (-0.53%)

    +3.00 (+0.17%)
  • DOW

    +183.56 (+0.55%)

    +233.92 (+1.69%)
  • CMC Crypto 200

    +10.47 (+2.65%)
  • Nasdaq

    +123.45 (+1.13%)
  • ^FTAS

    -11.44 (-0.28%)

The Global Infectious Disease Market is expected to grow by $104.81 bn during 2023-2027, accelerating at a CAGR of 12.49% during the forecast period


Global Infectious Disease Market 2023-2027 The analyst has been monitoring the infectious disease market and it is poised to grow by $104. 81 bn during 2023-2027, accelerating at a CAGR of 12.

New York, Nov. 21, 2022 (GLOBE NEWSWIRE) -- announces the release of the report "Global Infectious Disease Market 2023-2027" -
49% during the forecast period. Our report on the infectious disease market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of infectious diseases, growing awareness of infectious diseases, and a strong drug pipeline.

The infectious disease market is segmented as below:
By Product
• Drugs
• Vaccines

By End-user
• Hospital
• Multispecialty clinic
• Others

By Geography
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the development of novel drugs as one of the prime reasons driving the infectious disease market growth during the next few years. Also, increasing mergers and acquisitions and the emergence of new patterns of infectious diseases will lead to sizable demand in the market.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters. Our report on the infectious disease market covers the following areas:
• Infectious disease market sizing
• Infectious disease market forecast
• Infectious disease market industry analysis

This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading infectious disease market vendors that include Bio Rad Laboratories Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, Siemens AG, Sysmex Corp., Trinity Biotech Plc, Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, DiaSorin SpA, Quidel Corp., and Thermo Fisher Scientific Inc. Also, the infectious disease market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001